Michael Ristow

Michael Ristow ( born April 24, 1967 in Lübeck ) is a German doctor ( internist ) and scientists. He is a professor of energy metabolism at the ETH Zurich with the research field of mitochondrial metabolism and its possible significance for the development of diseases such as type 2 diabetes mellitus ( sugar diabetes ), obesity, and cancer, as well as its importance in general aging.

Ristow has substantial contributions to the mitochondrial control of cancer tissue published and supported by experiments in cell lines, the Warburg hypothesis.

Ristows recent work in humans and in the model organism Caenorhabditis elegans suggest that oxidative stress and free radicals and reactive oxygen species ( ROS) - a vaccine comparable - be able to prolong life or health. This process was called " Mitohormesis ", and is based on Ristows aforementioned hypothesis that antioxidants can shorten the life expectancy in that they prevent the formation of oxygen radicals. An independent meta-analysis was analogous manner to the conclusion that people in the administration of certain antioxidants (beta-carotene, vitamin C and E ) may promote the development of diseases.

Recent work from Ristows Group produce a correlation between the content of lithium and the life expectancy between high content of trace element and high life expectancy, there is a statistically significant relationship; further extend high lithium concentrations, the life expectancy of the model organism Caenorhabditis elegans.

Published as a nutritionist and commented Ristow research results, address the adverse effects of antioxidants and so-called ACE sports drinks (enriched with vitamins A, C and E) on health.

2004 Ristow was awarded the Ferdinand- Bertram - Award of the German Diabetes Society.

Writings

• Subcloning and expression studies of a new ATP-dependent transmembrane transporter NG -TRA in tissues of rats and humans. Bochum, Univ., Diss, 1996